Objective-We have shown previously that oxidized LDL decreases insulin-like growth factor-1 (IGF-1) and IGF-1 receptor expression in vascular smooth muscle cells and that IGF-1 and IGF-1 receptor expression are reduced in the deep intima of early atherosclerotic lesions. Because oxidized LDL is potentially important for the depletion of vascular smooth muscle cells contributing to plaque destabilization, we studied the role of IGF-1 in oxidized LDL-induced apoptosis. Methods and Results-We provide evidence that oxidized LDL-induced apoptosis is caused by decreased mitochondrial membrane potential and increased cytochrome C release in human aortic vascular smooth muscle cells. Overexpression of the IGF-1 receptor by using an adenovirus completely abrogated these effects. The antiapoptotic function of the IGF-1 receptor was associated with increased Akt kinase activity and increased expression of phosphorylated Bad. Moreover, a dominant-negative p85 phosphatidylinositol 3-kinase adenovirus blocked the capacity of the IGF-1 receptor to prevent oxidized LDL-induced apoptosis. Conclusions-Our data demonstrate that IGF-1 receptor activation inhibits oxidized LDL-induced cytochrome C release and apoptosis through the phosphatidylinositol 3-kinase/Akt signaling pathway and suggest that genetic or pharmacological activation of the IGF-1 receptor may be a useful strategy to stabilize atherosclerotic plaques. 
A therosclerosis is the leading cause of mortality in the Western world. Oxidative modification of LDL is widely believed to be involved in the pathogenesis of atherosclerosis and in destabilization of the atherosclerotic plaque. [1] [2] [3] Foam cells, one of the hallmarks of atherosclerotic plaque, develop when monocyte-derived macrophages or vascular smooth muscle cells (VSMCs) within the arterial wall take up oxidized LDLs (oxLDLs) via scavenger receptors. OxLDLs can induce apoptosis of endothelial cells 4 -6 and VSMCs 7 in vitro, and oxLDLs are associated with the apoptosis of VSMCs in human atherosclerotic plaques. 8 We have recently shown that oxLDLs reduce insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in VSMCs 9 and that IGF-1/IGF-1R expression is reduced in areas of atherosclerotic plaque. 8, 10 Because of the potent survival effects of IGF-1, 11, 12 these findings provide a putative mechanism whereby oxLDLs could contribute to plaque apoptosis.
Although the precise pathways mediating the survival action of IGF-1 are unclear, these effects are mediated through the type 1 IGF-1R, which possesses intrinsic tyrosine kinase activity and activates a number of downstream mediators, including phosphatidylinositol 3-kinase (PI3-kinase)/ Akt and mitogen-activated protein kinase (MAPK). [13] [14] [15] [16] Both MAPK and particularly PI -kinase/Akt have been implicated in IGF-1 and growth factor-induced survival effects. 16 -18 The survival effects of Akt are mediated by phosphorylation and inhibition of several proapoptotic proteins, such as Bad, 19 caspase 9, 20 and the Forkhead transcription factors. 11, 21 Activation of Akt has been shown to prevent the release of cytochrome C from mitochondria, 22 which occurs as a result of mitochondrial membrane permeabilization 23, 24 and which is a critical event in both stress and death receptor-induced apoptosis. 25, 26 On entry into the cytosol, cytochrome C binds the caspase-activating protein Apaf-1, stimulating its binding to procaspase 9 and activating caspase networks that trigger apoptosis. 27 There is limited information on the effect of oxLDL on mitochondrial function, 28, 29 and the potential roles of oxLDLs mediated IGF-1 and IGF-1R downregulation in mitochondrial dysfunction and apoptosis are unknown.
In this study, we investigated the effects of oxLDLs on mitochondrial function, the release of cytochrome C and apoptosis in VSMCs, and the ability of IGF-1R activation to rescue cells from oxLDL-induced apoptosis. Our findings demonstrate that oxLDLs trigger loss of mitochondrial membrane potential and cytochrome C release, leading to apoptosis in VSMCs. Furthermore, overexpression of the IGF-1R completely rescues VSMCs from these effects through a PI3-kinase/Akt-dependent pathway. These findings have major implications for devising a strategy to limit the loss of VSMCs that contribute to the destabilization of advanced atherosclerotic plaque and could contribute to aneurysm rupture. 30, 31 
Materials and Methods
See online Materials and Methods, which can be accessed at http://atvb.ahajournals.org.
Results

Effects of oxLDL, IGF-1, and Overexpression of IGF-1R on Cell Viability
To determine the effect of IGF-1R overexpression on oxLDL-induced cytotoxicity, we incubated human airway smooth muscle cells (HASMCs) with native LDL (nLDL) or oxLDL (0 to 60 g/mL) for 7, 16, or 24 hours in the presence or absence of IGF-1R adenovirus (AdIGF-1R). We found that oxLDL caused a reduction in HASMC viability at 24 hours but not at 7 and 16 hours, whereas nLDL did not affect cell viability (see online Figure IA , which can be accessed at http://atvb.ahajournals.org). In addition, the cells were transiently exposed to oxLDLs for 7 or 16 hours, the oxLDLs were then removed, and new culture media were added and toxicity determined at 24 hours after the initial exposure to oxLDLs. Cytotoxicity was induced after 16 but not 7 hours of exposure to oxLDLs ( Figure IB ). Both IGF-1 and des-(1,3)-IGF-1 (des-IGF-1) partially protected against oxLDLinduced cytotoxicity when added with oxLDL for 24 hours ( Figure IC) . The rationale for using des-IGF-1 is that it has markedly lower affinity for IGF binding proteins and that the effect of IGF-1 independent of IGF binding proteins can be assessed. However, overexpression of IGF-1R using AdIGF-1R totally protected HASMCs against oxLDLinduced loss of cell viability, whereas overexpression of the control adenovirus, AdGFP, had no protective effect ( Figure  ID) . To determine the specificity of the effect of overexpressing the IGF-1R to prevent oxLDL-induced apoptosis, we performed additional experiments to determine whether other growth factors, namely basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF)-BB, can partially rescue VSMCs from the proapoptotic effect of oxLDLs. Because adenoviral constructs for these growth factor receptors are not available to us, we looked at the effect of adding exogenous growth factor to VSMCs in the presence of oxLDLs. As shown in the Figure 1 , neither PDGF-BB nor bFGF rescued VSMCs from the effects of oxLDLs, whereas des-IGF-1 significantly blunted the effect of oxLDLs.
To determine the principal components of oxLDL-induced cell death, we measured apoptosis by flow cytometry ( Figure  2A ) and by death ELISA ( Figure 2B ). OxLDLs caused a marked increase in Annexin-V staining ( Figure 2A ) and in antihistone and anti-DNA antibody binding ( Figure 2B ). Overexpression of the IGF-IR caused marked inhibition of oxLDL-induced apoptosis ( Figure 2B ). A, Flow cytometry. HASMCs were incubated for 24 hours in serum-free medium alone or with 60 g/mL nLDL or oxLDL and then stained for annexin V and propidium iodide, after which fluorescence-activated cell sorting analysis was performed immediately. Cells staining positive for Annexin V-FITC and negative for propidium iodide were considered as undergoing apoptosis. B, Death ELISA. HASMCs were infected with AdGFP or AdIGF-1R overnight and then exposed to serum-free medium alone (SFM) or with 60 g/mL nLDL or oxLDL for 24 hours and analyzed for histone-associated DNA fragments as described in the Materials and Methods. **PϽ0.001 compared with AdGFP/nLDL; *PϽ0.005 compared with AdIGF-1R/nLDL; ¶PϽ0.01 compared with AdGFP/oxLDL.
Effects of oxLDLs and Overexpression of IGF-1R on ⌬⌿
To determine the mechanisms by which oxLDLs induce apoptosis, we incubated HASMCs with various concentrations of oxLDLs. We found that oxLDLs caused a concentration and time-dependent decrease in ⌬⌿ and that a dose of 60 g/mL oxLDL decreased ⌬⌿ at 7 hours but not at 2 hours (see online Figure II , which can be accessed at http:// atvb.ahajournals.org). In contrast, nLDLs did not affect ⌬⌿.
Overexpression of IGF-1R using AdIGF-1R completely inhibited the oxLDL-induced loss of mitochondrial membrane potential. (Figure 3 ).
Effects of oxLDLs and Overexpression of IGF-1R on the Release of Cytochrome c
To examine the role of cytochrome C in oxLDL-induced apoptosis, we incubated HASMCs with oxLDLs for various lengths of times. We found that oxLDLs increased cytosolic cytochrome C levels ( Figure 4A ) at 16 hours but not at 7 hours. In addition, the cells were exposed to oxLDLs for 7 or 16 hours, the oxLDLs were removed, new culture media were added, and cytochrome C release was determined 24 hours after the initial exposure to oxLDLs. The cytochrome C release induced after 16 hours was still present at 24 hours despite removal of oxLDLs (not shown). nLDLs did not affect cytosolic cytochrome C levels. IGF-1 partially attenuated this oxLDL-induced increase in cytosolic cytochrome C levels ( Figure 4B ). However, IGF-1R overexpression using AdIGF-1R totally blocked the oxLDLinduced cytosolic cytochrome C release ( Figure 4C ).
Mechanisms Underlying the Ability of IGF-1R to Rescue Cells from oxLDL Cytotoxicity
To delineate the signal transduction pathways involved in the ability of the IGF-1R to rescue cells from oxLDL-induced apoptosis, we investigated the dual PI3 kinase/Akt and MAPK pathways. We found that infection of VSMCs with an adenovirus encoding the full-length IGF-1R increased the expression of IGF-1R ( Figure 5A ), the expression of phosphor-Akt and phosphor-Bad ( Figure 5A ), and phosphorErk42/44 (not shown). However, the overexpression of IGF-1R did not alter the expression of total Akt ( Figure 5A ) and total Erk42/44 (not shown). Moreover, the overexpression of GFP did not change the expression of IGF-1R, phosphor-Erk42/44, and phosphor-Akt. In vitro Akt kinase assays show that overexpression of the IGF-1R increased the activity of Akt kinase ( Figure 5B ). The dominant-negative PI3 kinase construct and the PI3 kinase inhibitor LY294002 blocked the ability of overexpressed IGF-1R to increase Akt kinase activity ( Figure 5B ). Neither the MAPKK (MEK) inhibitor PD98059 nor the control virus AdGFP altered the ability of AdIGF-1R to increase Akt kinase activity.
The PI3 kinase inhibitor LY294002 dose dependently blocked the ability of the overexpressed IGF-1R to rescue cells from oxLDL-induced apoptosis ( Figure 6A) . Moreover, infection with a dominant-negative PI3 kinase adenovirus (AdDN85) also inhibited the ability of the IGF-1R to block oxLDL-induced apoptosis ( Figure 6B ). In contrast, the MEK Figure 4 . Effects of oxLDL, IGF-1, and overexpression of IGF-1R on cytosolic cytochrome C levels. Cytosolic cytochrome C levels were assayed by ELISA as described in the Materials and Methods. The results were expressed as a percentage of the control Ϯ SEM. A, HASMCs were exposed to nLDLs (60 g/mL) or oxLDLs (60 g/mL) for 2.5, 7, or 16 hours. *PϽ0.01 compared with control, ¶PϽ0.01 compared with nLDL. B, HASMCs were exposed to serum-free medium alone (control) or with 60 g/mL oxLDL in the absence or presence of IGF-1: IGF(2), IGF-1, 2 ng/mL; IGF(10) IGF-1, 10 ng/mL; IGF(50), IGF-1 50 ng/mL. ¶PϽ0.0025 compared with control, *PϽ0.025 compared with oxLDL, **PϽ0.005 compared with oxLDL. C, HASMCs were incubated alone (control) or with 60 g/mL oxLDL for 24 hours or were infected with AdGFP or AdIGF-1R for 24 hours and then incubated with or without oxLDL (60 g/mL) for 16 hours. *PϽ0.01 compared with control, ¶PϽ0.01 compared with AdGFP. Figure 3 . Effects of oxLDL and overexpression of IGF-1R on mitochondrial membrane potential. HASMCs were incubated alone (control) or with 60 g/mL oxLDL for 7 hours or were infected with AdGFP or AdIGF-1R for 24 hours and then incubated with or without oxLDL (60 g/mL) for 7 hours, washed with PBS 3 times, and mitochondrial membrane potential was measured using RH123 as described in the Materials and Methods. The results were expressed as a percentage of the control Ϯ SEM. *PϽ0.01 compared with control, **PϽ0.01 compared with AdGFP.
inhibitor PD98059 did not block IGF-1R-induced rescue from oxLDL-triggered apoptosis (not shown). These data indicate that the ability of the overexpressed IGF-1R to prevent oxLDL-induced loss of mitochondrial membrane potential, cytochrome C release, and apoptosis is mediated by the PI3 kinase/Akt pathway.
Discussion
The major finding of this study is that robust activation of the IGF-1R signaling pathway (and specifically of PI3-K/Akt) via overexpression of the IGF-1R completely rescues VSMCs from the apoptotic effects of oxLDLs. This finding has major implications for understanding the mechanisms of VSMC loss in atherosclerotic plaques because we have shown recently that oxLDLs reduce IGF-1 and IGF-1R expression in VSMCs in vitro 9 and that areas of atherosclerotic plaque associated with expression of oxLDLs and increased VSMC apoptotic rates have lower expression of IGF-1/IGF-1R. 8, 10 Indeed, Patel et al 32 have shown that VSMCs from atherosclerotic plaque have reduced IGF-1R and reduced survival in vitro. Our findings may also be relevant to mechanisms of endothelial cell and macrophage damage in atherosclerotic lesions because both these cells may undergo apoptosis and/or nonapoptotic cell death in response to oxLDLs. 28, 29, 33 The other major finding of our study is that oxLDLs rapidly reduced mitochondrial membrane potential, resulting in cytosolic release of cytochrome c, and that this mechanism is critical for the apoptotic effect of oxLDLs on VSMCs and is completely inhibited by IGF-1R overexpression.
Our data showed that 7-hour of exposure to oxLDLs decreased ⌬⌿ without affecting cytochrome C release or apoptosis. Thus, the decrease in ⌬⌿ occurred before the release of cytochrome C (at 16 hours), suggesting that cytochrome C release induced by oxLDLs was a consequence of mitochondrial permeability transition pore opening. Our Figure 6 . The PI3 kinase pathway mediates IGF-1R-induced rescue from oxLDL-triggered cell death. A, HASMCs were treated with 0 to 50 mol/L PI3 kinase inhibitor LY294002 with or without AdIGF-1R for 24 hours and then exposed to oxLDL (0 to 60 g/mL) for another 24 hours before cell viability was measured. Results are expressed as a percentage of the control Ϯ SEM. ¶PϽ0.0025 compared with control (absence of oxLDL); *PϽ0.025 compared with AdIGF-1R ϩ oxLDL; **PϽ0.0025 compared with AdIGF-1RϩoxLDL. B, HASMCs were incubated alone (control) or with 60 g/mL oxLDL for 24 hours or were infected with AdIGF-1R or AdDN85 or their combination for 24 hours and then exposed to oxLDL (0 to 60 g/mL) for another 24 hours. Cell viability was determined and expressed as a percentage of the control Ϯ SEM. *PϽ0.01 compared with control; **PϽ0.05 compared with AdDN85; ¶PϽ0.025 compared with AdDN85 ϩ AdGFP; #PϽ0.005 compared with AdIGF-1R ϩ oxLDL. Figure 5 . Effect of AdIGF-1R on the expression of IGF-1R, phosphor-Akt, and phosphor-Bad. A, HASMCs were infected with AdIGF-1R or control AdGFP for 24 hours and cell lysates subjected to 10% SDS-PAGE, transferred to polyvinylidene fluoride membranes, and blotted with anti-IGF-1R␤, anti-actin, antitotal Akt, anti-pAkt, anti-total Bad, or anti-pBad antibody. Detection was by enhanced chemiluminescence. B, Effect of AdIGF-1R on the activity of Akt kinase. HASMCs were incubated alone (control) or infected with AdIGF-1R or AdGFP for 24 hours or treated with PI3 kinase inhibitor LY294002 (50 mol/L) or MAPKK inhibitor PD98059 (50 mol/L) in addition to being infected with AdIGF-1R for 24 hours or infected with AdIGF-1R and a dominant-negative PI3 kinase adenovirus (AdDN85). After Akt immunoprecipitation, an Akt kinase assay was conducted using GSK-3 fusion protein as substrate, and Western blotting was used to determine Akt kinase activity by measuring the level of phosphorylation of GSK-3 fusion protein with antiphospho-GSK3 ␣/␤ antibody.
findings are consistent with reports that mitochondrial impairment leads to Apaf-1 activation of caspase networks, leading to apoptosis. 34 Moreover, the finding that only oxLDLs (and not nLDLs) could induce cytochrome C release and the fact that cytochrome C release (at 16 hours) occurred before toxicity was induced (at 24 hours) indicate that oxLDL-induced toxicity requires the release of cytochrome C from mitochondria, which is consistent with previous findings that cytochrome C release is necessary for apoptosis in many cell lines. 23, 35 The IGF-1R signaling pathway has been shown to be a potent survival signal for a variety of cell types in vitro. 11, 12, 36, 37 Depending on the cell type and the apoptotic stimuli, the survival effects can be mediated through the MAPK and/or protein kinase B (PKB)/Akt pathways. 13, 36 In addition, novel pathways may be involved. 38 -40 Mechanisms whereby oxLDLs can induce apoptosis of VSMCs are incompletely understood but may include changes in stimulation of tumor necrosis factor receptors 41 and Fas, 41, 42 MAP, and Jun kinases, 43 and the generation of reactive oxygen species. 44 Our previous report that oxLDLs downregulate IGF-1/ IGF-1R expression in rat aortic VSMCs 9 (which we have reproduced using HASMCs; P. Delafontaine, unpublished results, 2003) suggested that downregulation of this autocrine pathway could play a pivotal role in oxLDL-induced apoptosis of VSMCs. Indeed, our present findings demonstrating the ability of IGF-1R overexpression to rescue VSMCs from oxLDL-induced apoptosis suggest strongly that reduced signaling through this pathway plays an important role in oxLDL apoptotic effects. Furthermore, the inability of excess exogenous IGF-1 (or des-IGF-1) to fully rescue cells from oxLDL apoptosis suggests that IGF-1R density is a critical regulator of IGF-1-mediated survival effects, analogous to the critical role of IGF-1R density in IGF-1 mitogenic responses in VSMCs [45] [46] [47] and other cell types. 48 -51 Furthermore, the ability of IGF-1R overexpression to prevent an oxLDLinduced decrease in mitochondrial membrane potential and cytosolic cytochrome C release demonstrates that the overexpression of this receptor results in the inhibition of a mechanism that is central to both stress-induced and death receptor-induced apoptosis 25, 26 and that participates in nonapoptotic (oncotic) cell death. 29 Furthermore, these findings establish a central role for mitochondrial dysfunction in the apoptotic effects of oxLDLs on VSMCs, similarly to a recent report on oxLDL's effects on endothelial cells. 28 The present study examined the signaling pathways mediating the ability of the overexpressed IGF-IR to rescue VSMCs from oxLDL-induced apoptosis and documented that this survival pathway signals through PI3 kinase and Akt based on the following lines of evidence: (1) PI3 kinase inhibition abolished the ability of the overexpressed IGF-1R to prevent oxLDL-induced cytotoxicity; (2) overexpression of a dominant-negative PI3 kinase construct using AdDN85 abolished the capacity of the IGF-1R to preserve VSMC viability under oxLDL exposure; and (3) overexpression of IGF-1R increased the kinase activity of Akt and PI3 kinase inhibition and a dominant-negative AdDN85 blocked IGF-1R-induced Akt kinase activity. Although overexpression of IGF-1R increased the expression of phosphor-Erk42/44, the MEK inhibitor PD98059 (which acts upstream of Erk42/44) did not block IGF-1R-induced survival effects and the increase in Akt kinase activity. Taken together, these findings provide substantial evidence that PI3 kinase/Akt rather than MAPK is the dominant signaling pathway underlying IGF-1R-mediated inhibition of oxLDL-induced apoptosis of VSMCs. The marked increase in Akt phosphorylation and activity in response to IGF-1R overexpression would be expected to be a potent survival signal through the known ability of activated Akt to intervene in the apoptotic cascade upstream of the mitochondria, namely through its phosphorylation and inactivation of proapoptotic proteins Bad and potentially others. 52, 53 Our data that IGF-1R-triggered activation of Akt results in inhibition of oxLDL-induced changes in mitochondrial membrane potential and cytosolic cytochrome C release are consistent with the report that activated Akt can prevent UV light-mediated mitochondrial permeability change, cytosolic cytochrome C release, and cell death. 22 In view of our recent report demonstrating reduced IGF-1 and IGF-1R expression in atherosclerotic plaque in addition to the report by Patel et al 32 demonstrating reduced IGF-1R and reduced survival of VSMCs from atherosclerotic plaque, these findings have important implications for understanding mechanisms of VSMC depletion that could potentially contribute to plaque destabilization. Thus, there have been multiple reports that unstable plaques have a relative depletion of VSMCs, particularly in areas with a high number of inflammatory cells, such as the shoulder regions. 54 -57 Furthermore, unstable plaques are characterized by thin fibrous caps, again consistent with a relative paucity of VSMCs. 54 -57 The ability of oxLDLs to decrease IGF-1 and IGF-1R expression and, more importantly, the ability of IGF-1R overexpression to completely rescue VSMCs from oxLDLinduced cytotoxicity suggest that manipulation of the IGF-1/ IGF-1R autocrine system may offer an attractive strategy for plaque stabilization.
In summary, overexpression of the IGF-1R in VSMCs inhibits oxLDL-induced membrane permeabilization and cytochrome C release and rescues these cells from oxLDLinduced apoptosis through a PI3 kinase/Akt-dependent signaling pathway. These findings suggest that manipulation of the IGF-1/IGF-1R autocrine/paracrine pathway may be a useful strategy to limit the loss of VSMCs that contribute to atherosclerotic plaque destabilization.
